Articles

Show Preview: SLAS goes East

Washington, D.C., will host ‘what’s new in lab automation and screening’ for the SLAS2015 meeting
Written byLloyd Dunlap
| 14 min read

Society for Laboratory Automation and Screening

4th Annual Conference and Exhibition

Walter E. Washington Convention Center

Washington, D.C.

Feb. 7-11, 2015

WASHINGTON, D.C.—This year marks a significant milestone for the annual meeting of the Society for Laboratory Automation and Screening (SLAS), as SLAS2015 gets ready to convene Feb. 7-11 at the Walter E. Washington Convention Center in Washington, D.C.

“This meeting marks the first time SLAS will hold our annual meeting in D.C.,” notes Tom Manning, the organization’s director of marketing communications. Formed only four years ago by the merger of the Society for Biomolecular Sciences (SBS) and the Association for Laboratory Automation (ALA), the organization has quickly become the launching pad for what’s new in lab automation and screening. “We are excited about D.C. for a number of reasons,” Manning states, and lists off a few: “The location is easily accessible for much of the U.S. and is within driving distance for many East Coast residents. Furthermore, the D.C. location should enable more government scientists—often constrained by travel and training expenses—to participate in SLAS2015.”

In 2014, SLAS, headquartered near Chicago, set in motion a multiyear rotation between San Diego (even-number years) and D.C. (odd-number years) as the host city for the society’s flagship annual event.

San Diego readily attracts the biotechnology community, notes SLAS President Daniel Sipes, who represents that community in his “day job” with the Genomics Institute of the Novartis Research Foundation, where he is the director of advanced automation technologies. In addition to government types, Sipes adds that Big Pharma and European representatives are likely to find the East Coast location convenient.

Sipes notes that since the merger of the SBS and the ALA four years ago to form SLAS, the annual meeting has been structured with three pillars: education, exhibits and community. Many attendees, he observes, come principally for one of the three, particularly the exhibits, but post-event surveys have indicated all three aspects rate highly with attendees.

In terms of “education,” which we at DDNews tend to focus on in these show previews, SLAS2015 will feature 140 podium presentations across seven educational tracks, which are: Assay Development and Screening, Automation and High-Throughput Technologies, Bioanalytical Techniques, Biomarker Discovery and Applications, Drug Target Strategies, Micro- and Nanotechnologies and, finally, Informatics.

Manning notes that especially high-profile podium presentations (and authors) scheduled for SLAS2015 include the 10 finalists for the annual SLAS Innovation Award:

  • Droplet Microfluidics for High-Throughput Analysis and Sensing by Prof. Robert Kennedy, University of Michigan
  • Digital Microfluidic Immunocytochemistry in Single Cells (DISC) by Prof. Aaron Wheeler, University of Toronto
  • An Automated Open Platform for Exclusion-based Sample Preparation: Getting More Information from Limited Patient Samples by David J. Guckenberger, University of Wisconsin, Madison
  • Droplet-Based Three-Dimensional Cell Migration Assay with Flow Cytometry-Based Automated Analysis by Dr. Marie-Elena Brett, University of Minnesota
  • Novel Acoustic Loading of a Mass Spectrometer—Towards Next-Generation High-Throughput MS Screening by Dr. Jonathan Wingfield, AstraZeneca, Discovery Sciences
  • Automation of Droplet Manipulation Using Electrowetting on Film by Dr. Thomas D. Perroud, eFluidics
  • Annotating Biological Activities of Compounds by High-content Pathway Profiling Assays by Dr. Sergei S. Makarov, ATTAGENE
  • The Simoa HD-1 Analyzer: A Fully automated, Multiplexed Immunoanalyzer with Single Molecule Sensitivity by Dr. David C. Duffy, Quanterix Corp.
  • Zero Background in Homogeneous Proximity Assays Using Thermofluorimetric Analysis (TFA) for Quantitation of Attomole Protein Levels in Serum by Dr. Joonyul Kim, Auburn University
  • Bioinspired Spleen-on-a-chip for Sepsis Therapy by Dr. Joo Hun Kang, Wyss Institute/Harvard University

Interested parties can see presentation and session details for the items above and others, as well as the latest version of the scientific program, on the SLAS2015 Event Scheduler at www.eventscribe.com/2015/SLAS2015/

Special Sessions are also a highlight of the scientific program, Manning notes.

“Three unique Special Sessions have been curated especially for SLAS2015,” he observes. “Each of these includes multiple presentations focused on the broader theme of the session. Special Sessions at SLAS2015 include: European Government/Foundation Drug Discovery Collaboration; The Commercialization of New Technologies: From Ideas to Reality (presented by the SLAS Journal of Laboratory Automation); and An Evening with NIH, which will be moderated by Chris Austin, director of the National Center for the Advancement of Translational Sciences.”

Keynote presenters include Dr. Donald Ingber, Judah Folkman Professor of Vascular Biology, professor of bioengineering and founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, who will address SLAS2015 on Monday, Feb. 9, as well as NIH Director Dr. Francis Collins on Wednesday, Feb. 11, and Laurie Garrett, author and noted authority on global health issues on Wednesday night.

And then there is the “exhibit” part of the three pillars of SLAS meetings, which Manning calls “another highlight.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.